Regenerative medicine company Juventas Therapeutics is touting the results from 12-month data of a phase 1 clinical trial of heart failure patients.At 12 months, heart failure patients treated with the company’s stem cell therapy showed “significant” improvements in two key measures — a six-minute distance-walking test, as well as the Minnesota Living with Heart Failure [...]
[Read more of this report]One of Northeast Ohio’s leading physician-entrepreneurs is leaving Cleveland Clinic to join Akron’s Summa Health System.Dr. Marc Penn will become director of research for the Summa Cardiovascular Institute and also a professor at Northeast Ohio Medical University (NEOMED) in Rootstown, according to a statement from Summa. Penn will start with Summa next month. His five-person [...]
[Read more of this report]